Monday, December 11, 2023

Your Immediate Action required

Hello there!

Unfortunately, there are some bad news for you.

Some time ago your device was infected with my private trojan,
R.A.T (Remote Administration Tool), if you want to find out more
about it simply use Google.

My trojan allows me to access your accounts, your camera and
microphone.

Check the sender of this email, I have sent it from your email
account.

You truly enjoy checking out porn websites and watching dirty
videos, while having a lot of kinky fun.

I RECORDED YOU (through your camera) SATISFYING YOURSELF!

If you still doubt my serious intentions, it only takes couple
mouse clicks to share the video of you with your friends,
relatives, all email contacts and on social networks.

All you need is $1200 USD in Bitcoin (BTC) transfer to my account
(Bitcoin equivalent based on exchange rate during your transfer).

After the transaction is successful, I will proceed to delete
everything without delay.

Afterwards, we can pretend that we have never met before.

In addition, I assure you that all the harmful software will be
deleted from your device.

Be sure, I keep my promises!

If you are unaware how to buy and send Bitcoin (BTC) - Google:
Where to buy Bitcoin (BTC), to send and receive Bitcoin (BTC),
you can register your wallet for example here: www.blockchain.com

My Bitcoin (BTC) address is: 1KAdBCJGueNZnu4wuUxDTU58N7xXDyfmGg

Yes, that's how the address looks like, copy and paste my
address, it's (cAsE-sEnSEtiVE).

You are given not more than 48 hours after you have opened this
email (2 days to be precise).

As I got access to this email account, I will know if this email
has already been read.

Everything will be carried out based on fairness!

An advice from me - regularly change all your passwords to your
accounts and update your device with newest security patches.

don't test me
be smart

Did You Miss This... The "Smart Money" Is Ready for Dec. 12th. Are You?

Former Goldman Sachs Vice President and Best-selling retirement expert steps...
If you are having trouble viewing this email, click here.

The "Smart Money" Is Ready for Dec. 12th. Are You?


Some of America's best "Doomsday" investors are buying one stock right now...

And on December 12th, you'll understand why.

This stock has a track record of holding its own during bloodbaths.

Last year, when the market got so ugly it was compared to the Great Depression – this stock gained 37%... and the Smart Money took note.

  • The man who landed a $100 million dollar payday during 1987's Black Monday Crash is buying in...
  • As is the billionaire mathematician who made a killing during both the dot-com Crash and 2008's Financial Crisis...

Today, former Goldman Sachs trader, Dr. David Eifrig, (another veteran of the Black Monday Crash) is stepping forward to warn anyone with market exposure about December 12th.

He believes what happens on this day could hurt any investors who don't pay close attention.

And is urging any American who cares about their money or retirement to consider this stock immediately, too.

Get the facts here, and then decide for yourself.

Just, please, don't sit idly by and do nothing.

See Dr. Eifrig's full, brand-new analysis here...

Sincerely,

Kelly Brown
Senior Researcher, Stansberry Research.

P.S. Perhaps you read the New York Times article titled "The Man Who Won as Others Lost". It was about the man I just mentioned, who banked $100 million during Black Monday.

Today, you are getting a chance to position yourself alongside him.

But I wouldn't wait around.

This ad is sent on behalf of Stansberry Research, 1125 N Charles St, Baltimore, MD 21201.



We just wanted to take a moment and say thank you so much for being part of our family! We are dedicated to teaching people how to make the world a better place so we can all thrive, together. We love sharing stories and featuring past learners who have applied our teachings and changed their situations. It's our passion to build a strong community centered around fun and mindset! We love to discover extraordinary and useful tools and share them with the world! We create a space where people can discover how to enjoy their lives by simply choosing to learn. Every day we are building and strengthening partnerships with our customers and clients and we do so in the most ethical way possible. We particularly love working with artisans, makers, and small businesses because through their passion and their craft they help make the world a better place.. Without all of you we wouldn't be able to do what we do on a daily basis and for that we say thank you. We've been living our dream for many years now and that wouldn't be possible without every single one of you. The idea of going from a typical nine to five life to a life of freedom doesn't seem real to most people, but we want you to know it is definitely possible. We've done it. You have the power to control your life, your actions, and what you choose to focus on. We're here to help you along that journey to achieve whatever goals you set out for yourself. However, we also care about keeping you and your privacy safe. We are committed to advising you of the right to your privacy. We strive to provide a safe and secure user experience. Our Privacy Policy explains how we collect, store and use personal information, provided by you on our website. It also explains how we collect and use non-personal information. By accessing and using our website, you explicitly accept, without limitation or qualification, the collection, use and transfer of the personal information and non-personal information in the manner described in this Privacy Policy. Please read this Policy carefully, as it affects your rights and liabilities under the law. If you disagree with the way we collect and process personal and non-personal information, please do not use this website. This Policy applies to this website as well as all webpages Company hosts. It regulates the processing of information relating to you and grants both of us various rights with respect to your personal data. It also informs you of how to notify us to stop using your personal information. We are located in the United States of America. You may be located in a country that has laws which are more restrictive about the collection and use of your personal information. However, by using our website, you agree to waive the more restrictive laws and agree to be governed by the laws of the United States of America. If you wish to view our privacy policy, you can find it below.

From time to time your free Trading Tips newsletter subscription is supplemented by paid sponsorships, like the one above. Please read all disclaimers. Rest assured that your information was not shared with this sponsor. Please note that Trading Tips has not independently reviewed the validity of the claims or statements contained within this sponsorship, and we are not responsible for any errors or omissions.

Never invest in a security or idea featured on our site or in our emails unless you can afford to lose your entire investment. We are not registered investment advisors or brokers/dealers and we do not purport to be. We make no representations, warranties or guarantees as to the accuracy or completeness of the content featured on our site or in our emails. Furthermore, the article authors and contributors featured on this site may own securities mentioned in their articles and not disclose this information. Trading Tips does not endorse any investing or trading products or newsletters advertised in this email or on our web site. Please be sure to read our Terms & Conditions, Disclaimer and Privacy Policy.

Go here to get more information from http://www.TradingTips.com

 

This email was sent to edwardlorilla1986.paxforex@blogger.com by editor@tradingtips.com

TradingTips.com | 3435 Ocean Park Blvd. Suite 107-334Santa Monica, CA 90405

Manage Subscriptionsreport SPAM


 

Turn $5,000 into $1.17 million, in as little as eight months

 
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ � �� ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌&n bsp;‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ 
Perry's Quick Income Trader
Fellow Investor,

Investors are panicking, wondering when the bottom’s gonna fall out...

But my beta testers are excited.

They have the opportunity to bank an amazing fourth-straight million-dollar year.

Let me show you how:

Starting with just $5,000, we gobbled up seven figures in 2020 DESPITE the Covid crash... and made $1.08M in nine months.

And just to prove we can make money in a bull market too... in 2021 we started with just five grand, and we banked $1.04M in nine months.

But in 2022, when the market nosedived... our system went into overdrive and we turned $5,000 into $1.17M in only EIGHT months.

And here’s the thing:

Investing in this system is NOT rocket science.

You don’t have to be a skilled investor to be a beta tester. It’s a very simple way to trade.

All you have to do is follow my directions – what to buy, when to buy, and when to sell – and watch the wins pile up fast in this push-button system.

And you can be one of my next beta testers.

But I’m only opening 87 new slots today. And based on our past successes, I know these slots will go fast.

Click here now to be one of the lucky 87.
Click Here Now to Learn More >
Sincerely,
Bryan Perry
Bryan Perry
Investment Director, Eagle Financial
Click Here Now To Be One Of The Lucky 87 >
Eagle Financial Publications - Eagle Products, LLC. - a Salem Communications Holding Company
122 C Street NW, Suite 515 | Washington, D.C. 20001

My Fergie bet was a 💩

I don't use the same strategy to trade as I do with Draft Kings  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

December 11, 2023   |   Read Online

My Fergie bet was a 💩

I don't use the same strategy to trade as I do with Draft Kings

tw
 

Update your email preferences or unsubscribe here

62 Calef Hwy. #233
Lee, NH 03861, United States of America

AI’s arrived in rural health

The ideas and innovators shaping health care
Dec 11, 2023 View in browser
 
Future Pulse

By Daniel Payne, Ruth Reader, Carmen Paun, Erin Schumaker and Evan Peng

INNOVATORS

Bill Gassen smiling for a portrait.

Bill Gassen. | Courtesy of Sanford Health

Bill Gassen, president and CEO of Sanford Health, a South Dakota-based health system with hundreds of locations across the upper Midwest, isn’t waiting for the future of artificial intelligence. His health system is bringing the tech to every corner of its operations.

That could mean significant changes for health providers of all sorts — not only in their clinical work but also in how they conduct business. Gassen talked to Daniel about how the system is using AI.

This interview has been edited for length and clarity.

How are you using AI now?

First in clinical support and then for business improvement in the back office.

If you look at the first one, we’ve got a team that’s developed algorithms that are helping us do a better job of predictive analytics for our patients so we can intervene earlier.

On the back-office side, they’ve developed algorithms that help us do everything from nurse staffing to helping us schedule our infusion chairs.

There has been some reporting about AI turning billing processes upside down — are you using it in that area?

Those are opportunities for us to drive down costs that aren’t delivering a direct benefit to patients.

If I’ve got a dollar, do I want to invest that in clinical advancement? Do I want to invest that in research? Do I want to invest in continuing to advance the workforce, to bring in more physicians and more nurses and more technicians? Or do I want to have to invest that in back-office support?

If I can drive down some of those costs, it does free up more opportunity to invest.

You’re also interested in what Congress does about pandemic-era telehealth policies, which are set to expire next year, right?

Simply stated: We need those to be permanent.

Everybody believes and knows that leveraging technology in a different way is a critical part of the pathway forward — I believe it’s probably our single most powerful weapon to allow us to address the issues of access and equity and to make sure that we’re doing better for all those patients.

If those waivers go away, there’s not a sustainable business model around it.

WELCOME TO FUTURE PULSE

St. John, U.S. Virgin Islands.

St. John, U.S. Virgin Islands. | Shawn Zeller/POLITICO

This is where we explore the ideas and innovators shaping health care.

Here’s one job we didn’t expect AI to threaten: sommelier. But an artificial intelligence algorithm identified which estates 80 Bordeaux red wines came from with 100 percent accuracy, Science reports. It was so good it could distinguish wines made on one side of France’s Garonne River from those made on the other.

Share any thoughts, news, tips and feedback with Carmen Paun at cpaun@politico.com, Daniel Payne at dpayne@politico.com, Evan Peng at epeng@politico.com, Ruth Reader at rreader@politico.com or Erin Schumaker at eschumaker@politico.com.

Send tips securely through SecureDrop, Signal, Telegram or WhatsApp.

Today on our Pulse Check podcast, host Kelly Hooper talks with Carmen, who explains why abortion has Congress deadlocked over the reauthorization of the President's Emergency Plan for AIDS Relief, or PEPFAR, a program credited with saving 25 million lives.

Play audio

Listen to today’s Pulse Check podcast

WORKFORCE

A nurse takes the pulse of a patient at a free health clinic.

Doctors say patients do better when doctors are in charge, a new survey found. | John Moore/Getty Images | Getty

Most physicians think patient care deteriorates when insurance companies, hospitals, private equity firms or staffing agencies take over doctor-owned medical practices, according to a new survey.

NORC, based at the University of Chicago, polled 1,000 doctors who work at practices with non-physician owners and found nearly 60 percent thought it affected care quality either significantly or somewhat for the worse. The survey was commissioned by the Physicians Advocacy Institute.

The top reason they believe care worsened: It reduced their autonomy to make decisions about patient care.

Those who believed the change was bad for patients also noted an increased administrative burden, financial incentives playing a larger role in operations and less time to talk with the people they treat.

Even so: Most — 63 percent — reported having high levels of independence.

And, nearly 1 in 4 doctors didn’t see any effect on patient care under new ownership, while about 1 in 5 thought the ownership change benefited patients.

Those who saw improvements cited technology and infrastructure updates and increased attention to patient outcomes.

FOLLOW THE MONEY

Drug capsules are seen on the production line at the plant of French multinational pharmaceutical company Pierre Fabre.

Pharma investment is down, but some areas remain strong. | Gerard Julien/AFP via Getty Images

After a pandemic-era spending spree, investors are rethinking whether to sink money into biopharmaceuticals, according to a new report from industry analyst Pitchbook.

The report estimates 84 deals worth $17.9 billion will be made in 2023 and said venture capitalists are making fewer deals with bigger price tags.

The report outlines a few areas of interest:

— Molecules discovered with artificial intelligence

— Gene therapies like CRISPR

— mRNA technology

— Cell therapies like CAR-T

— Emerging treatments that use nanotechnology for precision medicine and bacteriotherapy

— Weight-loss drugs

Even so: The report warns some of these investments could be overhyped:

— Artificial intelligence-enhanced drug discovery has yet to prove that it’s better than traditional methods.

— Gene therapy is highly regulated, and insurers won’t necessarily reimburse it.

— Cell therapies are complicated to manufacture and can come with severe side effects.

Emerging treatments, by virtue of their newness, will face unknown regulatory hurdles and technical challenges.

The takeaway: Despite an overall decline in the amount of money going into biopharmaceuticals, investors are still finding areas of promise.

 

Follow us on Twitter

Carmen Paun @carmenpaun

Daniel Payne @_daniel_payne

Ruth Reader @RuthReader

Erin Schumaker @erinlschumaker

Evan Peng @thepngfile

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to edwardlorilla1986.paxforex@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Unsubscribe | Privacy Policy | Terms of Service

What Are Buffett, Dalio, and Druckenmiller So Worried About?

U.S. Market has quietly entered the 'Dead Zone' Dear Reader, As the market hits new highs... and the general public is feeling ...